• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

epilepsy

Biotech

Praxis ends year on high with $100M biobucks UCB deal

It’s been a tough year of layoffs and pipeline culls for Praxis, but the biotech is ending 2022 on a high courtesy of a collaboration with UCB.
James Waldron Dec 14, 2022 5:29am

Neurocrine's $45M bet goes 0 for 2 with rare epilepsy flop

Dec 7, 2022 7:20am

Kriya buys Redpin to chart gene therapy course in neurology

Nov 16, 2022 11:51am

Biohaven fuels up for post-Pfizer future with $302M

Nov 9, 2022 9:55am

New gene therapy for epilepsy hits seizures where they start

Nov 4, 2022 11:05am

Biohaven veers toward Kv7 platform following Pfizer sale

Oct 4, 2022 11:48am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy